celiac disease market

Celiac disease is an autoimmune disorder against the gluten consumed that creates toxins, thereby, destroying the villi. It affects almost 1 percent of the population worldwide. Celiac disease is a chronic autoimmune disorder that primarily affects the small intestine. It is triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. In individuals with celiac disease, consuming gluten leads to an immune response that damages the lining of the small intestine, impairing nutrient absorption and causing a range of gastrointestinal and systemic symptoms.

Gain rich insights into the Celiac disease, its signs, symptoms, causes, and diagnostics tests. Know more about its epidemiological statistics, available treatment scenario, Celiac disease marketed therapies available, and unmet needs in the market through our newsletter.

The newsletter brings an overlay of the Celiac disease market landscape, ongoing clinical trials, and therapies in the pipeline that are expected to transform the Celiac disease market in the next decade.

Know about the major pharma companies in the Celiac disease market landscape, the recent collaborations and agreements, and the happenings at the research front advancing the Celiac disease market landscape.

Subscribe for more.

Also, give it a good read to our latest blog: Celiac Disease: The Hidden Epidemic of Gluten Sensitivity